drugset / Trial / NCT02816437

FMT for MDRO Colonization in Solid Organ Transplant

NCT02816437 ↗

Phase 1 Withdrawn University of Miami
NaSingle-groupOpen-labelTreatment

Summary

This is a pilot feasibility study to determine whether fecal microbiota transplantation (FMT) can suppress or reverse gastrointestinal carriage of MDROs in hospitalized solid organ transplant recipients with a history of one or more MDRO infections.

Timeline

Start
2016-07
Primary completion
2022-10
Completion
2022-12

Outcome

Outcome not reported

Stopped: “safety”

Drugs

EvaluationDrugModalityDoseRoute
Subject OpenBiome Fecal Microbiota Transplantation Unknown 250 ml Rectal

Indications